Progesterone stimulates pancreatic cell proliferation in vivo.
Treatment of cyclic and pregnant rats with progesterone stimulates cell proliferation within the islets of Langerhans. It was investigated whether this effect of progesterone depends on sex and/or the presence of the gonads or the presence of oestradiol. For this purpose, Silastic tubes containing progesterone were inserted s.c. in intact and gonadectomized male and female rats, and in gonadectomized female rats treated with oestradiol. After 6 days of progesterone treatment, rats were infused for 24 h with 5-bromo-2'-deoxyuridine (BrdU) and dividing cells were identified in pancreatic sections by immunostaining for BrdU. Progesterone treatment increased islet-cell proliferation in intact male and female rats (P < 0.05), but not in gonadectomized male and female rats or in gonadectomized female rats supplemented with oestradiol. Furthermore, in intact male and female rats, progesterone treatment also stimulated cell proliferation in extra-islet pancreatic tissue (P < 0.05). Identification of the proliferating cells, by double-immunocytochemistry, revealed that progesterone treatment stimulated proliferation of both alpha and beta cells within the pancreatic islets. In extra-islet pancreatic tissue, progesterone treatment stimulated proliferation in both duct (cytokeratin 20-immunoreactive) and non-duct cells. Progesterone treatment did not increase the number of single glucagon or insulin-containing cells outside the pancreatic islets, nor that of cytokeratin 20/insulin double-positive cells, suggesting that progesterone treatment did not stimulate differentiation of duct cells into endocrine cells. Progesterone treatment did not affect insulin responses to an i.v. glucose load (0.5 g/kg body weight). It is concluded that progesterone stimulates pancreatic cell proliferation indirectly; gonadal factor(s), not identical to oestradiol, is (are) probably involved.
Nieuwenhuizen
A G
AG
Department of Obstetrics and Gynaecology, University of Groningen, The Netherlands.
Schuiling
G A
GA
Liem
S M
SM
Moes
H
H
Koiter
T R
TR
Uilenbroek
J T
JT
D004092:20-alpha-Dihydroprogesterone / Q000097:blood; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001973:Bromodeoxyuridine / Q000737:chemistry; D002455:Cell Division / Q000187:drug effects; D004958:Estradiol / Q000097:blood / Q000494:pharmacology*; D005260:Female; D005951:Glucose Tolerance Test / Q000662:veterinary; D007150:Immunohistochemistry; D007328:Insulin / Q000097:blood; D007515:Islets of Langerhans / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D008297:Male; D009919:Orchiectomy / Q000662:veterinary; D010052:Ovariectomy / Q000662:veterinary; D011247:Pregnancy; D011374:Progesterone / Q000097:blood / Q000494:pharmacology*; D011863:Radioimmunoassay / Q000662:veterinary; D051381:Rats; D017208:Rats, Wistar
D001786:Blood Glucose; D007328:Insulin; D004092:20-alpha-Dihydroprogesterone; D011374:Progesterone; D004958:Estradiol; D001973:Bromodeoxyuridine